Ramsay RE (1989). "Pharmacokinetics and clinical use of parenteral phenytoin, phenobarbital, and paraldehyde". Epilepsia. 30 (Suppl 2): S1–S3. doi:10.1111/j.1528-1157.1989.tb05818.x. PMID2767008.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
Plosker, GL (November 2012). "Stiripentol: in severe myoclonic epilepsy of infancy (dravet syndrome)". CNS Drugs. 26 (11): 993–1001. doi:10.1007/s40263-012-0004-3. PMID23018548.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
Tomson, T; Svanborg, E; Wedlund, JE (May–Jun 1986). "Nonconvulsive status epilepticus". Epilepsia. 27 (3): 276–85. doi:10.1111/j.1528-1157.1986.tb03540.x. PMID3698940.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
French, J; Smith, M; Faught, E; Brown, L (12 May 1999). "Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society". Neurology. 52 (8): 1540–5. doi:10.1212/WNL.52.8.1540. PMID10331676.
"Diacomit EPAR". European Medicines Agency. Diarsipkan dari versi asli tanggal 12 November 2020. Diakses tanggal 8 November 2020.Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
nih.gov
ncbi.nlm.nih.gov
Al-Otaibi, Faisal (2019-09-01). "An overview of structurally diversified anticonvulsant agents". Acta Pharmaceutica (Zagreb, Croatia). Walter de Gruyter GmbH. 69 (3): 321–344. doi:10.2478/acph-2019-0023. ISSN1846-9558. PMID31259739.
Joshi, A; Bow, A; Agius, M (2019). "Pharmacological Therapies in Bipolar Disorder: a Review of Current Treatment Options". Psychiatria Danubina. 31 (Suppl 3): 595–603. ISSN0353-5053. PMID31488797.
Keck, Jr., Paul E.; McElroy, Susan L.; Strakowski, Stephen M. (1998). "Anticonvulsants and antipsychotics in the treatment of bipolar disorder". The Journal of Clinical Psychiatry. 59 (Suppl 6): 74–82. PMID9674940.
Ramsay RE (1989). "Pharmacokinetics and clinical use of parenteral phenytoin, phenobarbital, and paraldehyde". Epilepsia. 30 (Suppl 2): S1–S3. doi:10.1111/j.1528-1157.1989.tb05818.x. PMID2767008.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
Plosker, GL (November 2012). "Stiripentol: in severe myoclonic epilepsy of infancy (dravet syndrome)". CNS Drugs. 26 (11): 993–1001. doi:10.1007/s40263-012-0004-3. PMID23018548.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
Suddock JT, Kent KJ, Cain MD. Barbiturate Toxicity. 2023 Apr 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID 29763050.( 26 / August / 2023 )
Isojärvi, JI; Tokola RA (December 1998). "Benzodiazepines in the treatment of epilepsy in people with intellectual disability". J Intellect Disabil Res. 42 (1): 80–92. PMID10030438.
Tomson, T; Svanborg, E; Wedlund, JE (May–Jun 1986). "Nonconvulsive status epilepticus". Epilepsia. 27 (3): 276–85. doi:10.1111/j.1528-1157.1986.tb03540.x. PMID3698940.Parameter |s2cid= yang tidak diketahui akan diabaikan (bantuan)
Djurić, M; Marjanović B; Zamurović D (May–Jun 2001). "[West syndrome--new therapeutic approach]". Srp Arh Celok Lek. 129 (1): 72–7. PMID15637997.
French, J; Smith, M; Faught, E; Brown, L (12 May 1999). "Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society". Neurology. 52 (8): 1540–5. doi:10.1212/WNL.52.8.1540. PMID10331676.
"Felbamate". MedlinePlus : U.S. National Library of Medicine. Diarsipkan dari versi asli tanggal 20 May 2013. Diakses tanggal 19 May 2013.Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
"Diacomit EPAR". European Medicines Agency. Diarsipkan dari versi asli tanggal 12 November 2020. Diakses tanggal 8 November 2020.Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
"Felbamate". MedlinePlus : U.S. National Library of Medicine. Diarsipkan dari versi asli tanggal 20 May 2013. Diakses tanggal 19 May 2013.Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)